pubmed-article:14726963 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C0054950 | lld:lifeskim |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C1456796 | lld:lifeskim |
pubmed-article:14726963 | lifeskim:mentions | umls-concept:C1705984 | lld:lifeskim |
pubmed-article:14726963 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:14726963 | pubmed:dateCreated | 2004-1-16 | lld:pubmed |
pubmed-article:14726963 | pubmed:abstractText | High levels of soluble CD30 (sCD30) were detected in the serum and synovial fluid of patients with rheumatoid arthritis (RA), indicating the involvement of CD30+ T cells in the pathogenesis. We investigated the induction of CD30 and its functions in CD4+T cells from patients with established RA (disease duration >_2 years). CD4+ T cells from both the peripheral blood (PB) and synovial tissue (ST) of RA patients expressed surface CD30 when stimulated with anti-CD3 antibody (Ab) and anti-CD28 Ab, but their CD30 induction was slower and weaker compared with PB CD4+ T cells of healthy controls (HC). Immunohistochemical analysis showed that only a small proportion of lymphocytes expressed CD30 in the ST (-1%). RA PB CD4+ T cells, after recovery from 6-day stimulation with anti-CD3 Ab and anti-CD28 Ab, showed in intracellular cytokine staining that CD30+ T cells could produce more interleukin-4 (IL-4) but less interferon-gamma. In the culture of RA PB CD4+ T Cells with anti-CD3 Ab and anti-CD28 Ab, blocking anti-CD30 Ab similarly inhibited the cell proliferation and activation of nuclear factor-kappaB on day 4 in RA and HC, but inhibited the apoptotic cell death on day 6 only in RA. These results indicate that despite high-level expression of sCD30, the anti-inflammatory activity of IL-4-producing CD30+ CD4+ T cells may be limited in the ST due to a poor induction of surface CD30 and a susceptibility to CD30-mediated cell death. | lld:pubmed |
pubmed-article:14726963 | pubmed:language | eng | lld:pubmed |
pubmed-article:14726963 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14726963 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14726963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14726963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14726963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14726963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14726963 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14726963 | pubmed:month | Dec | lld:pubmed |
pubmed-article:14726963 | pubmed:issn | 0386-300X | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:YamamuraMasah... | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:MakinoHirofum... | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:OkamotoAkiraA | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:AitaTetsushiT | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:KawashimaMasa... | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:IwahashiMitsu... | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:UenoAkikoA | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:YamanaJiroJ | lld:pubmed |
pubmed-article:14726963 | pubmed:author | pubmed-author:KagawaHidetos... | lld:pubmed |
pubmed-article:14726963 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14726963 | pubmed:volume | 57 | lld:pubmed |
pubmed-article:14726963 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14726963 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14726963 | pubmed:pagination | 267-77 | lld:pubmed |
pubmed-article:14726963 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:meshHeading | pubmed-meshheading:14726963... | lld:pubmed |
pubmed-article:14726963 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14726963 | pubmed:articleTitle | Pathophysiological functions of CD30+ CD4+ T cells in rheumatoid arthritis. | lld:pubmed |
pubmed-article:14726963 | pubmed:affiliation | Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan. | lld:pubmed |
pubmed-article:14726963 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14726963 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:943 | entrezgene:pubmed | pubmed-article:14726963 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:14726963 | lld:entrezgene |
lhgdn:association:61942 | lhgdn:found_in | pubmed-article:14726963 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14726963 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14726963 | lld:pubmed |